Study: Protein Mutation Protects Indian HIV Patients From AIDS Dementia
This article was originally published in PharmAsia News
A research team has determined India has a relatively low incidence of AIDS-induced dementia because of a mutation that occurs in Indian patients. Four percent of Indians infected with HIV get AIDS-induced dementia, while 45 percent of HIV patients in the West get the dementia, the study determined. Researchers ascribed the difference to Tat, a neuro-toxic protein in the AIDS virus that mutates naturally. The Indian strain, HIV1-C is the only strain of 10 that undergoes the mutation that leads to Tat being ineffective in Indians infected with HIV. (Click here for more
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.